Cited by 176Garlic and Onion StudiesMedicinal Plants and NeuroprotectionDementia and Cognitive Impairment Research

Garlic reduces dementia and heart-disease risk

Open access
Borek, Carmia·2006·The Journal of Nutrition

Abstract

Risk factors for cardiovascular disease, including high cholesterol, high homocysteine, hypertension and inflammation, increase the risk of dementia, including its most common form, Alzheimer's disease (AD). High cholesterol is also associated with elevated beta-amyloid (Abeta), the hallmark of AD. Oxidative damage is a major factor in cardiovascular disease and dementia, diseases whose risk increases with age. Garlic, extracted and aged to form antioxidant-rich aged garlic extract (AGE or Kyolic), may help reduce the risk of these diseases. AGE scavenges oxidants, increases superoxide dismutase, catalase, glutathione peroxidase, and glutathione levels, and inhibits lipid peroxidation and inflammatory prostaglandins. AGE reduces cholesterol synthesis by inhibiting 3-hydroxy-3-methylglutaryl-CoA reductase and is additive with statins in its action. Inhibition of cholesterol, LDL oxidation, and platelet aggregation by AGE, inhibits arterial plaque formation; AGE decreases homocysteine, lowers blood pressure, and increases microcirculation, which is important in diabetes, where microvascular changes increase heart disease and dementia risks. AGE also may help prevent cognitive decline by protecting neurons from Abeta neurotoxicity and apoptosis, thereby preventing ischemia- or reperfusion-related neuronal death and improving learning and memory retention. Although additional observations are warranted in humans, compelling evidence supports the beneficial health effects attributed to AGE in helping prevent cardiovascular and cerebrovascular diseases and lowering the risk of dementia and AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jn/136.3.810s

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AGE protected the brain from neurodegenerative diseases in an animal model by preventing brain injury following ischemia, saving neurons toward apoptosis, and inhibiting oxidative death caused by β-amyloid.

    “Borek [93] evaluated the neuroprotective effect of AGE using an animal model and they showed that AGE protected the brain from neurodegenerative diseases by preventing brain injury following ischemia, saving neurons toward apoptosis, and inhibiting oxidative death caused by β-amyloid [94].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Okuhara T. A clinical study of garlic extract on peripheral circulation. Jpn Pharmacol Ther. 1994;228:3695-701.
  2. Chun HS, Kim JM, Choi EH, Kim WK, Chang N. Neuroprotective effects of the garlic compound S-allyl cysteine on the in vitro and in vivo ischemic damage. Abstracts of the FASEB meeting. April 2003. FASEB J. 2003;17:A760 abst. #457.2.
  3. Nishiyama N, Moriguchi T, Katsuki H, Saito H. Effects of aged garlic extract on senescence accelerated mouse and cultured brain cells. In: Preclinical and clinical strategies for the treatment of neurodegenrative, cerebrovascular and mental disorders. Int Acad Drug Res. Basel Karger 1996;11:253-8.

Cited by

Sorted by citations

Authors
Borek, C.
Affiliations
Tufts University (US)
Corresponding author
Borek, Carmia
Venue
The Journal of Nutrition
Publisher
Elsevier BV
Published
2006-03
Volume
136
Issue
3
Pages
810S-812S
ISSN
0022-3166 (ISSN-L)
OpenAlex
W1899611968
Cited by
176
References
32
Citations by year
2026: 3 · 2025: 5 · 2024: 3 · 2023: 9 · 2022: 4 · 2021: 14 · 2020: 12 · 2019: 14 · 2018: 10 · 2017: 5 · 2016: 9 · 2015: 13 · 2014: 9 · 2013: 9 · 2012: 9
FWCI
13.36
Type
journal article
Language
en
Open access
Locations
  • Journal of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Garlic and Onion Studies
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
garlic, aged garlic extract, dementia, Alzheimer's disease, cardiovascular disease, cholesterol, homocysteine, amyloid-beta, oxidative stress, antioxidant enzymes, lipid peroxidation, statins, platelet aggregation, arterial plaque, blood pressure, microcirculation, diabetes mellitus, cognitive decline, neuroprotection
MeSH terms
Dementia, Garlic, Heart Diseases, Humans, Phytotherapy, Neoplasms, Plant Extracts, Thromboembolism, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review